Clinical Trials Directory

Trials / Completed

CompletedNCT02540239

Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
590 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To evaluate the efficacy, visibility of low volume polyethyleneglycol-simeticone (2-LPEG-S) for colonoscopy.

Detailed description

In this randomized controlled study, consecutive outpatients scheduled for elective colonoscopy were randomized into two groups. Group A patients (n = 300) used only 2 L PEG before colonoscopy. Patients in group B (n = 300) were additionally advised to simeticone plus 2 L PEG, The overall quality of colonoscopy cleaning was evaluated using the Boston Bowel Preparation Scale by a single endoscopist who was blinded to the intervention. Visibility was blindly assessed for the amount of air bubbles and adenoma detection rate (ADR). Difficulty of procedure, and adverse events were also evaluated.

Conditions

Interventions

TypeNameDescription
DRUG2L PEG
DRUG2L PEG+simethicone

Timeline

Start date
2015-01-01
Primary completion
2016-02-01
Completion
2016-04-01
First posted
2015-09-03
Last updated
2016-04-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02540239. Inclusion in this directory is not an endorsement.